Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

This study is currently recruiting participants.

Verified February 2013 by Otsuka Pharmaceutical Development & Commercialization, Inc.

Study NCT01418352 Information provided by Otsuka Pharmaceutical Development & Commercialization, Inc.

First Received on August 1, 2011. Last Updated on February 22, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Tourette's Disorder

Additional conditions recognized in this trial

Tourette Syndrome

More general conditions related to this trial

Interventions listed in this trial

aripiprazole

More general drug interventions related to this trial

Sponsors listed in this trial